STAT+: Pharmalittle: Panel tells FDA that CRISPR sickle cell therapy is safe enough for patients; U.K. is urged to scrap IP demands in trade talks with India

The U.K. government is being urged to scrap intellectual property demands in its trade negotiations with India, which critics say could threaten imports of cheap drugs.
Click here to view original post